Christos Kotanidis, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipose Tissue | 9 | 2023 | 3299 | 0.770 |
Why?
|
Arteritis | 1 | 2019 | 159 | 0.570 |
Why?
|
Coronary Artery Disease | 6 | 2024 | 6363 | 0.420 |
Why?
|
Medicine | 1 | 2020 | 942 | 0.410 |
Why?
|
Cardiovascular System | 1 | 2019 | 835 | 0.390 |
Why?
|
Radiation Injuries | 1 | 2019 | 1182 | 0.390 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2108 | 0.380 |
Why?
|
Acute Coronary Syndrome | 1 | 2024 | 2180 | 0.380 |
Why?
|
Myocarditis | 1 | 2018 | 766 | 0.350 |
Why?
|
Coronary Angiography | 4 | 2024 | 4451 | 0.350 |
Why?
|
Heart | 1 | 2022 | 4382 | 0.320 |
Why?
|
Plaque, Atherosclerotic | 4 | 2020 | 1505 | 0.250 |
Why?
|
Lymphocele | 1 | 2022 | 19 | 0.200 |
Why?
|
Adipokines | 2 | 2021 | 311 | 0.200 |
Why?
|
Endometrial Neoplasms | 2 | 2022 | 1357 | 0.190 |
Why?
|
State Medicine | 1 | 2022 | 213 | 0.180 |
Why?
|
Myocardial Revascularization | 1 | 2024 | 792 | 0.180 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15396 | 0.170 |
Why?
|
Ceramides | 1 | 2021 | 200 | 0.170 |
Why?
|
Coronary Vessels | 3 | 2020 | 3072 | 0.170 |
Why?
|
Tomography | 1 | 2021 | 411 | 0.160 |
Why?
|
Arteries | 2 | 2021 | 1125 | 0.160 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2019 | 242 | 0.150 |
Why?
|
ABO Blood-Group System | 1 | 2020 | 367 | 0.150 |
Why?
|
Osteoprotegerin | 1 | 2018 | 176 | 0.150 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 276 | 0.140 |
Why?
|
Awards and Prizes | 1 | 2021 | 359 | 0.140 |
Why?
|
Angiography | 1 | 2022 | 1599 | 0.140 |
Why?
|
Research Personnel | 1 | 2021 | 582 | 0.140 |
Why?
|
Endopeptidases | 1 | 2019 | 772 | 0.130 |
Why?
|
Interleukin-1 | 1 | 2019 | 1249 | 0.130 |
Why?
|
Syndrome | 1 | 2022 | 3262 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 4 | 2023 | 20500 | 0.120 |
Why?
|
Face | 1 | 2020 | 1017 | 0.120 |
Why?
|
Blood Vessels | 1 | 2019 | 1112 | 0.110 |
Why?
|
Ischemia | 1 | 2022 | 1863 | 0.110 |
Why?
|
Inflammation | 3 | 2024 | 10719 | 0.110 |
Why?
|
Oxidation-Reduction | 3 | 2023 | 2222 | 0.090 |
Why?
|
Acute Disease | 2 | 2021 | 7225 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15225 | 0.090 |
Why?
|
Humans | 21 | 2024 | 758381 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36285 | 0.090 |
Why?
|
Cardiology | 1 | 2021 | 1667 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10146 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2020 | 5199 | 0.090 |
Why?
|
Societies, Medical | 1 | 2021 | 3891 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4069 | 0.080 |
Why?
|
Atherosclerosis | 2 | 2021 | 3401 | 0.080 |
Why?
|
Obesity | 2 | 2021 | 12870 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2551 | 0.070 |
Why?
|
Cytokines | 1 | 2022 | 7338 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3783 | 0.070 |
Why?
|
Mental Health | 1 | 2021 | 3232 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2018 | 3941 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5105 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12604 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9405 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20052 | 0.050 |
Why?
|
Risk Assessment | 5 | 2024 | 23883 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54136 | 0.050 |
Why?
|
Aged | 7 | 2024 | 168217 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12951 | 0.050 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2020 | 65 | 0.040 |
Why?
|
Superoxides | 1 | 2021 | 386 | 0.040 |
Why?
|
Myocardium | 2 | 2023 | 4690 | 0.040 |
Why?
|
Sphingolipids | 1 | 2021 | 173 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 374 | 0.040 |
Why?
|
Oxidants | 1 | 2019 | 169 | 0.040 |
Why?
|
Female | 9 | 2024 | 390316 | 0.040 |
Why?
|
Pericardium | 1 | 2023 | 674 | 0.040 |
Why?
|
Germany | 1 | 2020 | 868 | 0.040 |
Why?
|
Parity | 1 | 2020 | 925 | 0.030 |
Why?
|
Prognosis | 3 | 2024 | 29558 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23341 | 0.030 |
Why?
|
Hysterectomy | 1 | 2022 | 904 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2022 | 1303 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2019 | 687 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39060 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2022 | 2943 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2019 | 3593 | 0.030 |
Why?
|
Genetic Markers | 1 | 2019 | 2608 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3612 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2019 | 1486 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1655 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 22031 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3258 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 219560 | 0.030 |
Why?
|
Menopause | 1 | 2020 | 1639 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1629 | 0.020 |
Why?
|
Adipocytes | 1 | 2018 | 1177 | 0.020 |
Why?
|
Risk Factors | 3 | 2024 | 73806 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2019 | 1160 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2023 | 9518 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3485 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1878 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3100 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6821 | 0.020 |
Why?
|
Adiposity | 1 | 2019 | 1858 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2021 | 4429 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2895 | 0.020 |
Why?
|
Male | 6 | 2024 | 358742 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8426 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14481 | 0.020 |
Why?
|
Cell Movement | 1 | 2019 | 5201 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11152 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10495 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3211 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10112 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4048 | 0.020 |
Why?
|
Animals | 3 | 2023 | 167777 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 6955 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12440 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11424 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11471 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12876 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16534 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10653 | 0.010 |
Why?
|
Adult | 3 | 2021 | 219916 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22006 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15785 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 87888 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13959 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81107 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42058 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58681 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 58808 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80170 | 0.010 |
Why?
|
Child | 1 | 2018 | 79813 | 0.010 |
Why?
|